Valmark Advisers Inc. bought a new stake in MaxCyte, Inc. (NASDAQ:MXCT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 83,927 shares of the company’s stock, valued at approximately $394,000. Valmark Advisers Inc. owned about 0.08% of MaxCyte […]
Related Keywords
United States , William Blair , Alberta Investment Management Corp , Maxcyte Company Profile , Maven Securities , Sg Americas Securities , Blair William Co , Exchange Commission , Valmark Advisers Inc , Nasdaq , Maxcyte Inc , Valmark Advisers , Free Report , Investment Counsel , Investment Management Corp , Get Free Report , Maxcyte Daily , Maxcyte , Nasdaq Mxct , Mxct , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,
comparemela.com © 2020. All Rights Reserved.